Isomorphic Labs
Company isomorphiclabs.com ● Covered in 5 stories + Follow ✴ AI Graph
Isomorphic Labs is Google's AI drug discovery subsidiary focused on using AI to identify novel drug targets and design therapeutics. The company raised $2.1 billion in a Series B funding round in H1 2026 and has developed the Isomorphic Drug Design Engine, which predicts drug-protein interactions and identifies previously unknown binding pockets on disease-associated proteins. Recently, Isomorphic Labs partnered with Google DeepMind on a bioresilience program to establish safeguards around AI use in biological contexts while making tools like AlphaFold available to government and biosecurity partners.
Updated 6 August 2026
Signals
0 stories (-100%)
Media momentum
As of 17 Sep 2026 · Visible stories in the last 30 days, compared with the 30 days before.
5 sources
Source diversity
As of 17 Sep 2026 · Distinct publications behind this entity's visible coverage.
—
Release activity
As of 17 Sep 2026 · Model, product and open-source release events in the last 90 days whose coverage involves this entity.
1 event
Funding signals
As of 17 Sep 2026 · Funding and acquisition events in the last 90 days whose coverage involves this entity.
Jun 2026 → Aug 2026
Coverage span
As of 17 Sep 2026 · First to most recent month of TLDRocket coverage of this entity.
Funding history
-
€1.8 billion Series B confirmed coverage →
Latest developments
Europe tech funding sees bigger deals, fewer winners
Startups Magazine ·
44
Fewer Deals, Larger Rounds: European Tech Companies Raise 30 Billion Euros in H1 2026
Trending Topics · 1 month ago ·
36
Our approach to bioresilience
Google DeepMind · 2 months ago ·
30
How a Google DeepMind Spin-off Hunts Hidden Drug Targets
IEEE Spectrum · 3 months ago ·
26
Q3 2026
- Google just announced a major shakeup of its top AI leadership
- Europe tech funding sees bigger deals, fewer winners
- Fewer Deals, Larger Rounds: European Tech Companies Raise 30 Billion Euros in H1 2026
- Our approach to bioresilience
Q2 2026
Relationships
Products & technology
- Develops IsoDDE · 1 source
- Develops Isomorphic Drug Design Engine · 1 source
- Derived from Google DeepMind · 1 source
Partnerships
- Partnered with Novartis · 1 source
- Partnered with Eli Lilly · 1 source
- Google DeepMind partnered with this company · 1 source
Investment & ownership
- Owns Alphabet · 1 source